INT236981

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 2.45
Pain Relevance 0.55

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (ISCA1) structural molecule activity (ISCA1)
ISCA1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 16 99.28 Very High Very High Very High
Pain 24 48.88 Quite Low
headache 28 5.00 Very Low Very Low Very Low
Potency 8 5.00 Very Low Very Low Very Low
corticosteroid 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 16 99.28 Very High Very High Very High
Erythema 16 91.20 High High
Pressure And Volume Under Development 24 90.56 High High
Body Weight 8 85.24 High High
Vasculitis 68 68.80 Quite High
Malaria 72 50.00 Quite Low
Pain 16 48.88 Quite Low
Leukemoid Reaction 44 5.00 Very Low Very Low Very Low
Headache 28 5.00 Very Low Very Low Very Low
Immunization 24 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Histopathology showed inflammation at the injection sites in all groups receiving Montanide ISA 51 formulations, including Pfs25/ISA 51, Pvs25/ISA 51, and PBS/ISA 51.
Negative_regulation (receiving) of ISA associated with inflammation
1) Confidence 0.05 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2440546 Disease Relevance 0.61 Pain Relevance 0.14
Histopathology showed inflammation at the injection sites in all groups receiving Montanide ISA 51 formulations, including Pfs25/ISA 51, Pvs25/ISA 51, and PBS/ISA 51.
Negative_regulation (receiving) of ISA associated with inflammation
2) Confidence 0.05 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2440546 Disease Relevance 0.62 Pain Relevance 0.14
Histopathology showed inflammation at the injection sites in all groups receiving Montanide ISA 51 formulations, including Pfs25/ISA 51, Pvs25/ISA 51, and PBS/ISA 51.
Negative_regulation (receiving) of ISA associated with inflammation
3) Confidence 0.05 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2440546 Disease Relevance 0.61 Pain Relevance 0.14
Histopathology showed inflammation at the injection sites in all groups receiving Montanide ISA 51 formulations, including Pfs25/ISA 51, Pvs25/ISA 51, and PBS/ISA 51.
Negative_regulation (receiving) of ISA associated with inflammation
4) Confidence 0.05 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2440546 Disease Relevance 0.61 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox